Marked liver tumorigenesis by helicobacter hepaticus requires perinatal exposure

Environmental Health Perspectives

Volumn 116, Issue 10, 2008, Pages 1352-1356

  Diwan, Bhalchandra A ^a   Sipowicz, Marek ^b   Logsdon, Daniel ^a   Gorelick, Peter ^a   Anver, Miriam R ^a   Kasprzak, Kazimierz S ^b   Anderson, Lucy M ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adult exposure; Helicobacter hepaticus; Hepatocellular tumors; Infection and cancer; Perinatal exposure

Indexed keywords

BACTERIAL TOXIN;

A J MOUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FECES ANALYSIS; FEMALE; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HEPATITIS; IMMUNOMODULATION; INCIDENCE; INFECTION SENSITIVITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; ANIMAL; LIVER TUMOR; MICROBIOLOGY; MOUSE STRAIN; PATHOGENICITY; PREGNANCY; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); HELICOBACTER HEPATICUS; MUS;

ANIMALS; FEMALE; HELICOBACTER HEPATICUS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED STRAINS; PREGNANCY; SPECIES SPECIFICITY;

EID: 55949100281     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11493     Document Type: Article

References (31)

1. Abdirad A, Ghaderi-Sohi S, Shuyama K, Koriyama C, Nadimi-Barforoosh H, Emami S, et al. 2007. Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades. Diagn Pathol 2:25; doi:10.1186/1746-1596-2-25 [Online 15 July 2007].
2. Anderson LM, Diwan BA, Fear NT, Roman E. 2000. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 108(suppl 3):573-594.
3. Arnold B, Schuler T, Hammerling GJ. 2005. Control of peripheral T-lymphocyte tolerance in neonates and adults. Trends Immunol 26:406-411.
4. Avenaud P, Castroviejo M, Claret S, Rosenbaum J, Megraud F, Menard A. 2004. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 318:739-745.
5. Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, et al. 2003. Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect Immun 71:3667-3672.
6. Blaser MJ, Chyou PH, Nomura A. 1995. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 55:562-565.
7. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. 2000. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 49:525-534.
8. Diwan BA, Ramljak D, Anver M, Gorelick PL, Ward JM, Hursting SD, et al. 2001. Persistent transmission of Helicobacter hepaticus via transplacental and/or translactational routes: induction of hepatitis and liver tumors in infected mice [Abstract]. Int J Med Microbiol 291(suppl 31):131.
9. Diwan BA, Ward JM, Ramljak D, Anderson LM. 1997. Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Pathol 25:597-605.
10. + regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 63:6042-6050.
11. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, et al. 1994. Helicobacter hepaticus sp nov., a microaerophilic bacterium isolated from liver and intestinal mucosal scrapings from mice. J Clin Microbiol 32:1238-1245.
12. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, et al. 1996a. Chronic proliferative hepatitis in A/J mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun 64:1548-1558.
13. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. 1996b. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 64:3673-3681.
14. Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, et al. 2005. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 73:3559-3567.
15. Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, et al. 2007. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 9:2070-2080.
16. Ihrig M, Schrenzel MD, Fox JG. 1999. Differential susceptibility to hepatic in.ammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 155:571-582.
17. Institute of Laboratory Animal Resources. 1996. Guide for Care and Use of Laboratory Animals. 7th ed. Washington, DC:National Academy Press.
18. Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. 1998. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun 66:5477-5484.
19. McCathey SN, Shomer NH, Schrenzel MD, Whary MT, Taylor NS, Fox JG. 1999. Colonization and tissue tropism of Helicobacter pylori and a novel urease-negative Helicobacter species in ICR mice are independent of route of exposure. Helicobacter 4:249-259.
20. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. 2006. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 74:4496-4504.
21. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wan YY, et al. 2006a. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 66:7395-7400.
22. Min#1/+ mice. Cancer Res 66:57-61.
23. Rice JM. 1995. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg Infect Dis 1:129-131.
24. Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, et al. 2004. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 32:668-677.
25. Singletary KB, Kloster CA, Baker DG. 2003. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp Med 53:259-264.
26. Sipowicz MA, Chomarat P, Diwan BA, Anver MA, Awasathi YC, Ward JM, et al. 1997. Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus. Am J Pathol 151:933-941.
27. Stuver SO. 1998. Towards global control of liver cancer? Semin Cancer Biol 8:299-306.
28. Ward JM, Anver MR, Haines DC, Benveniste RE. 1994a. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145:959-968.
29. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, et al. 1994b. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222-1227.
30. Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, et al. 2001. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp Med 51:413-417.
31. Young VB, Knox KA, Pratt JS, Cortez JS, Mansfield LS, Rogers AB, et al. 2004. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun 72:2521-2527.